The Journal of Phytopharmacology, 2020;9(4):281-290 DOI:10.31254/phyto.2020.9412
Antiviral efficacy of medicinal plants against respiratory viruses: Respiratory Syncytial Virus (RSV) and Coronavirus (CoV) / COVID 19
Lakshmi Narayanan Venu1 , Anoop Austin1
1. Cholayil Private Limited, Research & Development Centre, 31-A/24, 4th Cross Main Road, SIDCO Industrial Estate (North), Ambattur, Chennai – 600098, Tamil Nadu, India
*Author to whom correspondence should be addressed.
Received: 7th May, 2020 / Accepted: 22nd June, 2020
Respiratory syncytial virus (RSV) and Coronavirus disease (CoV) / Covid 19 are droplet infections caused by a group of RNA viruses infecting respiratory system and communicates through sneezing or physical contact. Due to the pandemic effect of Covid 19, it is essential to identify active components, which could be an active compound, which would be beneficial to the community such as respiratory syncytical virus (RSV) and coronavirus. 40 medicinal plants were screened basis the antiviral property pertaining to RNA virus and were dealt in detail to identify the plant which could be a source for developing a novel treatment for Respiratory Syncytical Virus and Covid 19. This review attempts to address the importance of herbs for the treatment of respiratory virus because rapid spread of the infection and preventing the use of allotropic medicine.
Antiviral Medicinal plants, Covid 19, Corona virus, Respiratory syncytial virus, Viral inhibiting plants.
HOW TO CITE THIS ARTICLE
Lakshmi Narayanan V, Anoop A. Antiviral efficacy of medicinal plants against respiratory viruses: Respiratory Syncytial Virus (RSV) and Coronavirus (CoV) / COVID 19. J Phytopharmacol 2020; 9(4):281-290.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.